Topic: London (England)

Mieulet et al.

Science - 536 days ago
2 Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. 4 Division of Immune Cell Biology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK. 5 Department of Chemical Pathology, Great Ormond Street Hospital for Sick ...

Early Treatment With Glatiramer Acetate Reduces Risk Of Progressing To ?Full-Blown? Multiple Sclerois By Almost Half (PreCISe study)

Drugs.com - 850 days ago
Glatiramer acetate is an approved drug for relapsing-remitting multiple sclerosis (MS). com) and in an upcoming edition of The Lancet shows that early treatment with this drug can reduce by almost half the risk of patients progressing from the very early signs ...

Rowling quits charity in 'conflict'

ThisIsLondon.co.uk - 1032 days ago
Harry Potter author JK Rowling has quit as patron of the MS Society Scotland, claiming the charity is being riven by an internal row.. "I also remain committed to financing future research into the treatment and causes of Multiple Sclerosis, and to ...

Horror clinical trial in test tube recreation

New Scientist - 1885 days ago
Devastating effects of a drug which left six healthy young men in intensive care during a disastrous drug trial in London, UK, have been replicated in a test tube. The preliminary results were presented in London today and form part of an ...